Jubilant Life Sciences Group
GPTKB entity
Properties (45)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
HollisterStier_in_2015
Jubilant_Pharma_in_2007 |
| gptkbp:awards |
Best Employer Award 2020
Excellence in Export Award 2021 Pharma_Company_of_the_Year_2019 |
| gptkbp:CEO |
gptkb:Shyam_S._Bhartia
|
| gptkbp:certifications |
gptkb:ISO_9001
EMA_Approved FDA_Approved |
| gptkbp:community |
Education Programs
Health Programs Skill Development Programs CSR Initiatives Environmental Sustainability Programs |
| gptkbp:employees |
Over 6,000
|
| gptkbp:focus |
Vaccines
Nutraceuticals Biosimilars Generic_Drugs Specialty_Pharmaceuticals |
| gptkbp:founded |
1978
|
| gptkbp:headquarters |
gptkb:Noida,_India
|
| https://www.w3.org/2000/01/rdf-schema#label |
Jubilant Life Sciences Group
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:investmentFocus |
Infrastructure Development
Market Expansion R&D Investment Technology Upgradation |
| gptkbp:market |
Global
|
| gptkbp:partnerships |
Government Agencies
Academic Institutions Research Organizations Various global pharmaceutical companies |
| gptkbp:products |
Radiopharmaceuticals
Active_Pharmaceutical_Ingredients Contract_Manufacturing_Services |
| gptkbp:research |
R&D_Centers_in_India_and_USA
|
| gptkbp:revenue |
$1 billion (2021)
|
| gptkbp:services |
Drug Discovery
Development Services Commercialization_Services |
| gptkbp:subsidiary |
gptkb:Jubilant_Pharma_Limited
gptkb:Jubilant_HollisterStier |
| gptkbp:website |
www.jubilantlifesciences.com
|